Display options
Share it on

Z Gesamte Inn Med. 1977 May 01;32(9):139-43.

[Drug treatment of hyperlipoproteinemias].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete

[Article in German]
M Hanefeld

PMID: 906593

Abstract

If by regulation of the ideal weight, by type-optimated diet and physical conditioning we do not succeed in a satisfying regulation of the hyperlipoproteinaemias, the indication to the medicamentous therapy is given. For the treatment of type IIa in the first place cholestyramine and essential phospholipids are taken into consideration, in unsatisfying effect the combination cholestyramin-regadrin. For the types IIb-V regadrin and preparations of nicotinic acid are the remedies of choice. In an unsatisfying decrease of lipids the combination regadrin-nicotinic acid and regadrin-buformin-respectively, should be used. To what extent by a medicamentous decrease of lipids a primary or secondary prevention of ischaemic vascular diseases is possible, at present cannot be answered definitively.

Substances

MeSH terms

Publication Types